TrialAnnals of surgical oncology2026

Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trial.

Tiantian Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.